-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Natalia Petruski-Ivleva, PhD

Articles by Natalia Petruski-Ivleva, PhD

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

Latest Updated Articles

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
December 8th 2021
eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
December 8th 2021

Trending on AJMC

As Employers Pull Back on GLP-1s, Andel and Novo Offer a Workaround

Birth Weight, Childhood Weight Gain Linked to Non-Hodgkin Lymphoma Risk

Myeloma Is Many Diseases, and Treatment Must Reflect That

October FDA Approvals Bring Advances Across 5 Specialties

Enlicitide LDL-C Lowering Holds Across Risk Levels Up to 2 Years